603363 傲農生物
按盤價 
3.560 +0.060 (+1.714%) | 2026/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 2,205,837 | 23.71% | 8,474,747 | 8,762,673 | 19,457,641 | 21,613,040 | |
| 減：營業總成本 | 2,283,919 | 26.15% | 8,694,993 | 10,238,603 | 22,210,699 | 22,475,331 | |
| 其中:營業成本 | 2,112,067 | 29.45% | 7,941,988 | 8,366,781 | 20,379,781 | 20,664,799 | |
| 財務費用 | 24,106 | -32.52% | 140,375 | 654,062 | 570,277 | 532,474 | |
| 資產減值損失 | -- | -- | (60,942) | (137,651) | (846,070) | (330,236) | |
| 公允價值變動收益 | 2,613 | -33,260.79% | (161) | (26,859) | 1,623 | (105,324) | |
| 投資收益 | 46,199 | -81.55% | 517,860 | 2,041,415 | (5,698) | (14,440) | |
| 其中：對聯營企業和合營企業的投資收益 | (1,761) | 35.70% | (13,124) | (7,219) | (20,255) | (9,492) | |
| 營業利潤 | (39,119) | -117.25% | 97,811 | 417,423 | (3,650,143) | (1,311,398) | |
| 利潤總額 | (37,992) | -116.86% | 105,339 | 84,495 | (3,681,632) | (1,295,035) | |
| 減：所得稅費用 | 4,830 | 29.96% | 15,931 | 21,403 | 87,053 | (69,213) | |
| 淨利潤 | (42,822) | -119.32% | 89,409 | 63,092 | (3,768,684) | (1,225,822) | |
| 減：非控股權益 | (29,492) | -976.27% | 11,787 | (516,253) | (117,862) | (187,456) | |
| 股東淨利潤 | (13,330) | -106.11% | 77,622 | 579,345 | (3,650,822) | (1,038,367) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.010 | -112.50% | 0.030 | 0.670 | -4.210 | -1.340 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 1.190 | 5.90% | 1.203 | 0.985 | -1.107 | 2.874 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 带有强调事项段、持续经营重大不确定性段落、其他信息段落中包含其他信息未更正重大错报说明的无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 18/05/2026 12:59 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
